Information  X 
Enter a valid email address

Xenetic Biosciences (XEN)

  Print      Mail a friend

Friday 27 January, 2012

Xenetic Biosciences

Holding(s) in Company

RNS Number : 2706W
Xenetic Biosciences PLC
27 January 2012

[27] January 2012

Xenetic Biosciences plc

('Xenetic' or 'the Company')


Share movement by Serum Institute of India Concert Party


Xenetic Biosciences plc (LSE: XEN.L), a bio-pharmaceutical company specialising in the development of high-value differentiated biological and vaccines and novel cancer drugs, announces that it was today informed by Serum Institute of India Limited that it has sold, 13 million Xenetic shares to a concert party company.


Buyer details are as follows:


Name                    Chanda Investment & Trading Co Pvt Ltd

Address                Pune

Trade Price         8.55 pence

No of shares      13,000,000


As a result of this transaction, the reported shareholding of Serum Institute of India and its related parties is unchanged, being, a total of 44,316,415 ordinary shares in the Company representing 11.67% of the Total Voting Rights.

- Ends -



Xenetic Biosciences plc

+44 (0)20 7389 5015

M. Scott Maguire, Chief Executive Officer

Singer Capital Markets (NOMAD & Broker)

+44 (0)20 3205 7500

Claes Spång

Walbrook PR

+44 (0)20 7933 8780

Paul McManus

Paul Cornelius


This information is provided by RNS
The company news service from the London Stock Exchange